These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 26030958)

  • 1. [Psoriasis and comorbidity--literature review].
    Owczarczyk-Saczonek A; Nowicki R
    Wiad Lek; 2014; 67(4):512-9. PubMed ID: 26030958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comorbidity in psoriasis].
    Gerdes S; Mrowietz U; Boehncke WH
    Hautarzt; 2016 Jun; 67(6):438-44. PubMed ID: 27221798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of smoking, alcohol consumption and metabolic syndrome in patients with psoriasis.
    Adışen E; Uzun S; Erduran F; Gürer MA
    An Bras Dermatol; 2018 Mar; 93(2):205-211. PubMed ID: 29723384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psoriasis and metabolic syndrome.
    Takahashi H; Iizuka H
    J Dermatol; 2012 Mar; 39(3):212-8. PubMed ID: 22035413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cardiovascular risk profile of patients with psoriasis].
    Di Lisi D; Macaione F; Corrado E; Bonura F; Novo G; Peritore A; Meschisi M; Cuttitta F; Bongiorno MR; Novo S
    Recenti Prog Med; 2013 Mar; 104(3):102-5. PubMed ID: 23548953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psoriasis is a systemic disease with multiple cardiovascular and metabolic comorbidities.
    Ryan C; Kirby B
    Dermatol Clin; 2015 Jan; 33(1):41-55. PubMed ID: 25412782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Integrated approach to comorbidity in patients with psoriasis.Working Group on Psoriasis-associated Comorbidities].
    Daudén E; Castañeda S; Suárez C; García-Campayo J; Blasco AJ; Aguilar MD; Ferrándiz C; Puig L; Sánchez-Carazo JL;
    Actas Dermosifiliogr; 2012 Jan; 103 Suppl 1():1-64. PubMed ID: 22364603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Examining the risk of cardiovascular disease in patients with psoriasis: a critical review.
    Papp K; Poulin Y; Vieira A
    J Cutan Med Surg; 2013; 17(2):89-105. PubMed ID: 23582163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic syndrome in Moroccan patients with psoriasis.
    Meziane M; Kelati A; Najdi A; Berraho A; Nejjari C; Mernissi FZ
    Int J Dermatol; 2016 Apr; 55(4):396-400. PubMed ID: 26712557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psoriasis and cardiovascular disorders.
    Ryan C; Menter A
    G Ital Dermatol Venereol; 2012 Apr; 147(2):179-87. PubMed ID: 22481581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Psoriasis is more than just a skin disease. Patients should be monitored for cardiovascular risk factor].
    Duvetorp A; Ljungberg A; Seifert O
    Lakartidningen; 2013 Oct 9-15; 110(41):1796-8. PubMed ID: 24187892
    [No Abstract]   [Full Text] [Related]  

  • 12. Psoriasis and comorbidities in a southern Brazilian population: a case-control study.
    Menegon DB; Pereira AG; Camerin AC; Cestari T
    Int J Dermatol; 2014 Nov; 53(11):e518-25. PubMed ID: 25070669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recommendations for detection of individual risk for comorbidities in patients with psoriasis.
    Wohlrab J; Fiedler G; Gerdes S; Nast A; Philipp S; Radtke MA; Thaçi D; Koenig W; Pfeiffer AF; Härter M; Schön MP
    Arch Dermatol Res; 2013 Mar; 305(2):91-8. PubMed ID: 23377136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psoriasis: comorbidities and associations.
    Farley E; Menter A
    G Ital Dermatol Venereol; 2011 Feb; 146(1):9-15. PubMed ID: 21317853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psoriasis: more than just a skin condition.
    Johns Hopkins Med Lett Health After 50; 2013 Nov; 25(11):3. PubMed ID: 24634954
    [No Abstract]   [Full Text] [Related]  

  • 16. Metabolic comorbidities and psoriasis.
    Gisondi P; Ferrazzi A; Girolomoni G
    Acta Dermatovenerol Croat; 2010; 18(4):297-304. PubMed ID: 21251450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors of hypertension, diabetes and obesity in Italian psoriasis patients: a survey on socio-demographic characteristics, smoking habits and alcohol consumption.
    Altobelli E; Petrocelli R; Maccarone M; Altomare G; Argenziano G; Giannetti A; Peserico A; Vena GA; Tiberti S; Chimenti S; Peris K
    Eur J Dermatol; 2009; 19(3):252-6. PubMed ID: 19220983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic comorbidities and hypertension in psoriasis patients in France. Comparisons with French national databases.
    Phan C; Sigal ML; Lhafa M; Barthélémy H; Maccari F; Estève E; Reguiai Z; Perrot JL; Chaby G; Maillard H; Bégon E; Alexandre M; Toussaint P; Bastien-Jacquin M; Bravard P; Sauque E; de Quatrebarbes J; Pfister P; Beauchet A; Mahé E;
    Ann Dermatol Venereol; 2016 Apr; 143(4):264-74. PubMed ID: 26969480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psoriasis as a systemic disease.
    Grozdev I; Korman N; Tsankov N
    Clin Dermatol; 2014; 32(3):343-50. PubMed ID: 24767182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psoriasis as the marker of underlying systemic disease.
    Kourosh AS; Miner A; Menter A
    Skin Therapy Lett; 2008 Feb; 13(1):1-5. PubMed ID: 18357363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.